ISPOR 2023 – inside the final plenary: electronic health records and causal inference

Electronic health records (EHRs) have huge potential to provide understanding on the effectiveness and safety of medicinal products, but their use as real-world data (RWD) sources remains challenging. Here, I share an overview and key takeaways from the final plenary session at ISPOR 2023 (7–10 May; Boston, MA, USA). The third and final plenary was titled “Issues and Solutions When Estimating Treatment Effects Using US Electronic Health Record Data”. Introduced by ISPOR Chief Scientific Offier, Richard Willke, the session was moderated by Sebastian Schneeweiss (Harvard Medical School and Brigham and Women’s Hospital, MA, USA) , who was joined by speakers Richie Wyss...